Skip to Content

Join the 'Bladder Cancer' group to help and get support from people like you.

Bladder Cancer News

Related terms: Cancer, Bladder

Cancer Advances Demand Continual Funding, Specialists Say

Posted 8 days ago by Drugs.com

TUESDAY, Nov. 29, 2016 – Sufficient and sustained funding for cancer research should be a global priority, European and American cancer organizations said at the start of an international oncology conference in Germany on Tuesday. Significant progress has been made in the understanding of how cancer develops. But, consistent research funding is needed to take advantage of these advances to improve cancer survival rates, according to specialists from two of the cancer organizations sponsoring the Munich meeting. "There has never been a more exciting time in cancer research," said Dr. Denis Lacombe, director general of the European Organisation for Research and Treatment of Cancer (EORTC). "With the surge in molecular biology developments and a growing consideration for cost-benefit balance from a public health perspective, there is an increasing need to invest in cancer research and ... Read more

Related support groups: Cancer, Breast Cancer, Prostate Cancer, Lung Cancer, Colorectal Cancer, Cervical Cancer, Bladder Cancer, Head and Neck Cancer

Low Vitamin D Levels May Raise Bladder Cancer Risk: Study

Posted 8 Nov 2016 by Drugs.com

TUESDAY, Nov. 8, 2016 – Low vitamin D levels may increase the risk of bladder cancer, researchers report. Five of seven studies the researchers reviewed linked low vitamin D levels with an higher risk of bladder cancer. In experiments with the cells that line the bladder, the researchers found that the cells activate and respond to vitamin D. This, in turn, can stimulate an immune response, the study authors said. The finding is important because the immune system may help prevent cancer by identifying and destroying abnormal cells before they develop into cancer, according to lead author Rosemary Bland, an honorary associate professor at the University of Warwick in England. "More clinical studies are required to test this association, but our work suggests that low levels of vitamin D in the blood may prevent the cells within the bladder from stimulating an adequate response to ... Read more

Related support groups: Cancer, Vitamin D Deficiency, Bladder Cancer, Caltrate 600 with D, Calcium/Vitamin D, Citracal + D, Citracal Petites, Oysco 500 with D, Calcarb with D, Calcium 600 D, Citracal Creamy Bites, Calcet, Oyster Shell Calcium, Citracal 250 mg + D, Oystercal-D, Os-Cal with D, Sedecal D, Calcio Del Mar, Oyster Shell Calcium with Vitamin D, Dical-D

Cancer Patients in Poorer Countries Often Go Without Radiation

Posted 2 Oct 2016 by Drugs.com

THURSDAY, Sept. 29, 2016 – Many cancer patients in low- and middle-income nations who would benefit from radiation treatment don't receive it, a new study finds. "In Ghana and the Philippines, for example, about eight in 10 cancer patients who need radiation therapy will not receive needed treatment," said study co-author Dr. Elena Fidarova, a researcher at the International Atomic Energy Agency in Vienna, Austria. She and her colleagues analyzed data from nine nations: Costa Rica, Ghana, Malaysia, the Philippines, Romania, Serbia, Slovenia, Tunisia and Uruguay. Overall, about five out of 10 cancer patients in these countries require radiation therapy to shrink tumors and kill cancer cells. But up to half of them do not have access to it, the researchers found. In individual nations, the rates of patients who can benefit from radiation therapy but do not receive it ranged from 18 to 82 ... Read more

Related support groups: Cancer, Breast Cancer, Prostate Cancer, Lung Cancer, Brain Tumor, Bladder Cancer, History - Radiation Therapy

More Cancer Patients Gaining From Immune-Based Treatments

Posted 20 Sep 2016 by Drugs.com

TUESDAY, Sept. 20, 2016 – A leading cancer group says more Americans are benefiting from immunotherapy – a relatively new treatment approach that helps the immune system target and destroy cancer cells. "The promise of immunotherapy for cancer therapy has never been greater, and the opportunity to make significant progress in this critical area is real," said Dr. Nancy Davidson, president of the American Association for Cancer Research (AACR). The AACR issued the news on immunotherapy as part of its 2016 Cancer Progress Report. As the group explained, more types of cancer are being successfully treated with immunotherapy. This treatment involves adding new cancer-fighting cells to the body or adding new elements, such as antibodies and proteins, to help the immune system fight cancer. In August 2015, one class of immunotherapy drugs – called checkpoint inhibitors – was approved for ... Read more

Related support groups: Lung Cancer, Non-Small Cell Lung Cancer, Melanoma, Melanoma - Metastatic, Bladder Cancer, Opdivo, Head and Neck Cancer, Keytruda, Hodgkin's Lymphoma, Tecentriq, Nivolumab, Pembrolizumab, Atezolizumab

Women's Cancer Risk Rises With Years Spent Overweight

Posted 16 Aug 2016 by Drugs.com

TUESDAY, Aug. 16, 2016 – The longer a woman is overweight, the higher her risk of several cancers, researchers report. The study, which followed nearly 74,000 U.S. women, found that the longer a woman carried excess poundage, the greater her risk of breast, endometrial, colon and kidney cancers. "We've known for a long time that excess weight is important in cancer risk," said Susan Gapstur, vice president of epidemiology for the American Cancer Society. The cancer society says excess weight contributes to as many as 20 percent of all cancer deaths. "This study is interesting because it suggests that the number of years you spend being overweight also matters," said Gapstur, who was not involved in the research. And that, she said, should provide further incentive to avoid excess weight gain in the first place. Currently, about 7 out of 10 adults in the United States are overweight, ... Read more

Related support groups: Obesity, Cancer, Weight Loss, Breast Cancer, Colorectal Cancer, Pancreatic Cancer, Ovarian Cancer, Bladder Cancer, Urinary Tract Cancer

New Guidelines Issued for Cancer Patients' Post-Treatment Pain

Posted 29 Jul 2016 by Drugs.com

FRIDAY, July 29, 2016 – More people are surviving cancer, but many are left with persistent pain after treatment. New guidelines from the American Society of Clinical Oncology (ASCO) recommend that doctors routinely screen for such pain. The guidelines also advise doctors to consider the use of non-traditional treatments for pain. These include hypnosis, meditation and medical marijuana where it's legal. ASCO also cautioned doctors to assess patients' risk for overuse of opioid painkillers. "Many oncologists and primary care physicians are not trained to recognize or treat long-term pain associated with cancer," guideline panel co-chair Judith Paice said in an ASCO news release. "This guideline will help clinicians identify pain early and develop comprehensive treatment plans, using a broad range of approaches," she said. Advances in cancer diagnosis and treatment have led to a record ... Read more

Related support groups: Pain, Suboxone, Oxycodone, Cancer, Hydrocodone, Methadone, Percocet, Tramadol, OxyContin, Vicodin, Norco, Fentanyl, Morphine, Codeine, Acetaminophen, Lortab, Tylenol, Chronic Pain, Opana, Ibuprofen

Cancer's Heavy Financial Burden

Posted 8 Jun 2016 by Drugs.com

WEDNESDAY, June 8, 2016 – Many cancer patients can't afford to see their doctor or take the medications they've been prescribed, a new study finds. And the problem will likely only get worse as the cost of cancer treatments continues to rise, the study authors said. "You can prescribe the best drug in the world, but if patients can't afford it and they can't get it, then it won't be effective," said study author Dr. Greg Knight. He is chief fellow with the University of North Carolina School of Medicine's division of hematology and oncology. "We saw a significant portion of patients in our study who were stretching their prescriptions or not coming to the doctor's office," Knight said in a university news release. The researchers reviewed survey results from nearly 2,000 patients at the N.C. Cancer Hospital in Chapel Hill, N.C. The participants were all 18 and older, and had been ... Read more

Related support groups: Cancer, Breast Cancer, Prostate Cancer, Lung Cancer, Gleevec, Colorectal Cancer, Brain Tumor, Votrient, Avastin, Tarceva, Melanoma, Skin Cancer, Nausea/Vomiting - Chemotherapy Induced, Tasigna, Sutent, Ovarian Cancer, Endometrial Cancer, Afinitor, Sprycel, Herceptin

Immune-Based Drug May Help Some With Advanced Bladder Cancer

Posted 5 Jun 2016 by Drugs.com

SUNDAY, June 5, 2016 – Patients with advanced bladder cancer can sometimes be too old or unhealthy to withstand standard chemotherapy. However, some may gain hope from a new drug that unleashes the immune system to attack tumor cells, researchers reported Sunday. Patients who responded to the drug Tecentriq (atezolizumab) had an average survival of nearly 15 months, about 5 to 6 months longer than people usually gain from platinum-based chemotherapy, said lead researcher Dr. Arjun Balar. The treatment didn't help everyone, however: Only about a quarter of patients responded to the drug. Still, any advance for this patient population is sorely needed, experts say. That's because about half of advanced bladder cancer patients cannot receive chemotherapy because they're too old to withstand chemo's toxic effects, explained Balar, who is assistant professor of medicine at NYU Langone ... Read more

Related support groups: Cancer, Bladder Cancer, Tecentriq, Atezolizumab

FDA Approves New Drug to Treat Bladder Cancer

Posted 31 May 2016 by Drugs.com

THURSDAY, May 19, 2016 – A new drug to treat bladder cancer was approved by the U.S. Food and Drug Administration on Wednesday. Tecentriq (atezolizumab) treats the most common type of bladder cancer, called urothelial carcinoma. It's the first in its class of drugs, called PD-1/PD-L1 inhibitors, approved to treat this type of cancer. "Tecentriq provides these patients with a new therapy targeting the PD-L1 pathway," Dr. Richard Pazdur, director of the office of hematology and oncology products in the FDA's Center for Drug Evaluation and Research, said in an agency news release. "Products that block PD-1/PD-L1 interactions are part of an evolving story about the relationship between the body's immune system and its interaction with cancer cells," he added. The FDA approved Tecentriq for treatment of patients with locally advanced or metastatic urothelial carcinoma whose disease has ... Read more

Related support groups: Bladder Cancer, Tecentriq, Atezolizumab

Global Recession May Have Contributed to Cancer Deaths

Posted 26 May 2016 by Drugs.com

THURSDAY, May 26, 2016 – The 2008 global economic crisis has been linked to a sharp rise in deaths from cancer, a new study reports. Unemployment and cuts in public health-care spending were associated with more than 260,000 additional cancer deaths by 2010. Most of those deaths – 160,000 – were in the European Union, the researchers said. The study included 70 countries and a total of more than 2 billion people, according to the report published online May 25 in The Lancet. "Cancer is a leading cause of death worldwide, so understanding how economic changes affect cancer survival is crucial," lead author Dr. Mahiben Maruthappu, of Imperial College London, said in a journal news release. "We found that increased unemployment was associated with increased cancer mortality, but that universal health coverage protected against these effects. This was especially the case for treatable ... Read more

Related support groups: Cancer, Breast Cancer, Prostate Cancer, Lung Cancer, Colorectal Cancer, Non-Small Cell Lung Cancer, Brain Tumor, Melanoma, Skin Cancer, Pancreatic Cancer, Ovarian Cancer, Endometrial Cancer, Cervical Cancer, Bladder Cancer, Melanoma - Metastatic, Stomach Cancer, Breast Cancer - Palliative, Gastric Cancer, Testicular Cancer, Solid Tumors

Too Many Advanced Cancer Patients Lack Info About Their Disease

Posted 23 May 2016 by Drugs.com

MONDAY, May 23, 2016 – Many patients battling advanced cancer lack basic information about their prognosis or treatment, meaning they can't make informed decisions about their care, a small new study suggests. "These were people with highly lethal metastatic cancers that had progressed after at least one prior line of chemotherapy; their life expectancy was approximately four months from our interview," said lead researcher Dr. Holly Prigerson. She is a professor of geriatrics at Weill Cornell Medicine in New York City. "We were astonished to learn that only 5 percent of this sample had sufficient knowledge about their illness to make informed decisions about their care," Prigerson said in a Weill Cornell news release. The findings highlight the need for doctors to improve communication with these patients, she said. In the study, Prigerson's team compared 178 advanced cancer patients' ... Read more

Related support groups: Cancer, Prostate Cancer, Lung Cancer, Colorectal Cancer, Brain Tumor, Pancreatic Cancer, Skin Cancer, Ovarian Cancer, Endometrial Cancer, Cervical Cancer, Bladder Cancer, Melanoma - Metastatic, Stomach Cancer, Head and Neck Cancer, Breast Cancer - Palliative, Gastric Cancer, Testicular Cancer, Solid Tumors

'Precision' Cancer Treatment May Extend Lives

Posted 20 May 2016 by Drugs.com

THURSDAY, May 19, 2016 – "Precision" cancer treatment that's guided by genetic clues from the patient's own tumor appears to outperform traditional chemotherapy, a new research review finds. Patients given precision – or personalized – treatment experienced a tumor shrinkage rate six times that attained by regular chemotherapy. But, that only happened if doctors used genetic information to choose the appropriate targeted therapy, said lead researcher Maria Schwaederle. Those patients also experienced nearly double the length of time before their cancer resumed growing, according to the analysis of nearly 350 clinical trials. "It is not just that the therapies are better, but that targeted therapies must be given to the right patients," said Schwaederle, who's with the University of California, San Diego School of Medicine's Center for Personalized Cancer Therapy. She will present ... Read more

Related support groups: Cancer, Methotrexate, Breast Cancer, Accutane, Tretinoin, Fluorouracil, Lung Cancer, Gleevec, Colorectal Cancer, Isotretinoin, Claravis, Tarceva, Xeloda, Skin Cancer, BCG, Tasigna, Revlimid, Zytiga, Hydroxyurea, Sprycel

FDA Approves Tecentriq (atezolizumab) for Urothelial Carcinoma

Posted 18 May 2016 by Drugs.com

May 18, 2016 – The U.S. Food and Drug Administration today approved Tecentriq (atezolizumab) to treat the most common type of bladder cancer, called urothelial carcinoma. This is the first product in its class (PD-1/PD-L1 inhibitors) approved to treat this type of cancer. "Tecentriq provides these patients with a new therapy targeting the PD-L1 pathway," said Richard Pazdur, M.D., director of the Office of Hematology and Oncology Products in the FDA’s Center for Drug Evaluation and Research. "Products that block PD-1/PD-L1 interactions are part of an evolving story about the relationship between the body’s immune system and its interaction with cancer cells." Tecentriq targets the PD-1/PD-L1 pathway (proteins found on the body’s immune cells and some cancer cells). By blocking these interactions, Tecentriq may help the body’s immune system fight cancer cells. Tecentriq is the first FD ... Read more

Related support groups: Cancer, Bladder Cancer, Tecentriq, Atezolizumab

Exercise May Cut Risk of 13 Cancers, Study Suggests

Posted 16 May 2016 by Drugs.com

MONDAY, May 16, 2016 – Exercise may significantly reduce your risk for many types of cancer, including some of the most lethal forms of the disease, a large review suggests. Working out for even a couple of hours a week appears to shrink the risk of breast, colon and lung cancer, said researchers who looked at 1.4 million adults. "Those are three of the four major cancers that affect Americans today," said Marilie Gammon. She is a professor of epidemiology with the University of North Carolina at Chapel Hill Gillings School of Public Health. And fitness buffs, take heart – your cancer risk appears to continue to decline as you rack up hours of physical activity, with no apparent upper plateau, said study lead author Steven Moore, an investigator with the U.S. National Cancer Institute. "The more activity, the more the benefit," Moore said. "As people did more, their risk continued to ... Read more

Related support groups: Cancer, Breast Cancer, Leukemia, Lung Cancer, Colorectal Cancer, Non-Small Cell Lung Cancer, Multiple Myeloma, Endometrial Cancer, Small Cell Lung Cancer, Acute Myeloid Leukemia, Bladder Cancer, Stomach Cancer, Head and Neck Cancer, Breast Cancer, Prevention, Acute Lymphoblastic Leukemia, Gastric Cancer, Osteolytic Bone Lesions of Multiple Myeloma, Urinary Tract Cancer, Acute Myeloblastic Leukemia

Well Water a Suspected Cause of Bladder Cancer in New England

Posted 3 May 2016 by Drugs.com

MONDAY, May 2, 2016 – Arsenic in drinking water from private wells may explain the elevated bladder cancer risk among people in three New England states, a new study suggests. Bladder cancer rates in Maine, New Hampshire and Vermont have been about 20 percent higher than the national rate for more than 50 years, the researchers noted. They said this difference was not explained by factors such as smoking or job exposures. "Arsenic is an established cause of bladder cancer, largely based on observations from earlier studies in highly exposed populations," said senior study author Debra Silverman. She is chief of the Occupational and Environmental Epidemiology Branch of the U.S. National Cancer Institute. "However, emerging evidence suggests that low to moderate levels of exposure may also increase risk," she added in an institute news release. Many people in these states have private ... Read more

Related support groups: Cancer, Bladder Cancer, Arsenic Trioxide, Trisenox

Page 1 2 3 4 Next

Ask a Question

Further Information

Related Condition Support Groups

Urothelial Carcinoma, Cancer

Related Drug Support Groups

methotrexate, cisplatin, cyclophosphamide, mitomycin, Adriamycin, doxorubicin, Tecentriq, Platinol, thiotepa, view more... Tepadina, Adriamycin PFS, Adriamycin RDF, atezolizumab, Mutamycin, Platinol-AQ, Thioplex